Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ARIYOSHI Y' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 64 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yamamori, E; Iwasaki, Y; Aoki, Y; Nomura, A; Tachikawa, K; Ariyoshi, Y; Mutsuga, N; Morishita, M; Yoshida, M; Asai, M; Oiso, Y; Saito, H
      Polyamine regulation of the rat pro-opiomelanocortin gene expression in AtT-20 cells

      JOURNAL OF NEUROENDOCRINOLOGY
    2. Ariyoshi, Y
      Preoperative determination of the location of parotid gland tumors by analysis of the position of the facial nerve - Discussion

      JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    3. Ariyoshi, Y; Shimahara, M
      Magnetic resonance imaging of maxillary cancer - possibility of detecting bone destruction

      ORAL ONCOLOGY
    4. Kawahara, M; Ariyoshi, Y; Fukuoka, M; Furuse, K
      Originality benefit and difficulty of clinical research in the West Japan Lung Cancer Group

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    5. Kubota, K; Tamura, T; Fukuoka, M; Furuse, K; Ikegami, H; Ariyoshi, Y; Kurita, Y; Saijo, N
      Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

      ANNALS OF ONCOLOGY
    6. Saito, H; Ogawa, M; Ariyoshi, Y
      The 15th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium "New immunological approach to cancer treatment" - Preface

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    7. Sawada, H; Ariyoshi, Y; Lee, K; Kyokane, J; Kawase, T
      A new approach to highly conductive polymer electrolytes: synthesis of gelling fluoroalkylated end-capped 2-acrylamido-2-methylpropanesulfonic acid copolymers containing poly(oxyethylene) units

      EUROPEAN POLYMER JOURNAL
    8. Furuse, K; Fukuoka, M; Kawahara, M; Nishikawa, H; Takada, Y; Kudoh, S; Katagami, N; Ariyoshi, Y
      Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    9. Ariyoshi, Y; Shimahara, M
      Mesenchymal chondrosarcoma of the maxilla: Report of a case

      JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    10. Kumada, T; Arai, Y; Itoh, K; Takayasu, Y; Nakamura, K; Ariyoshi, Y; Tajima, K
      Phase II study of combined administration of 5-flourouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer

      ONCOLOGY
    11. Hung, LW; Kohmura, M; Ariyoshi, Y; Kim, SH
      Structural differences in D and L-monellin in the crystals of racemic mixture

      JOURNAL OF MOLECULAR BIOLOGY
    12. Ota, M; Sawa, A; Nio, N; Ariyoshi, Y
      Enzymatic ligation for synthesis of single-chain analogue of monellin by transglutaminase

      BIOPOLYMERS
    13. SAWADA H; KATAYAMA S; ARIYOSHI Y; KAWASE T; HAYAKAWA Y; TOMITA T; BABA M
      FLUORINATED FUNCTIONAL MATERIALS POSSESSING BIOLOGICAL-ACTIVITIES - GEL FORMATION OF NOVEL FLUOROALKYLATED END-CAPPED 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID POLYMERS UNDER NON-CROSS-LINKED CONDITIONS

      Journal of materials chemistry (Print)
    14. FURUSE K; IKEGAMI H; ARIYOSHI Y
      2 PHASE-II STUDIES OF AMRUBICIN (SM-5887), A 9-AMINO-ANTHRACYCLINE, IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - WEST JAPAN LUNG-CANCER GROUP TRIALS

      Annals of oncology
    15. OTA M; ARIYOSHI Y
      SOLID-PHASE SYNTHESIS OF SINGLE-CHAIN MONELLIN, A SWEET PROTEIN

      Bioscience, biotechnology, and biochemistry
    16. HUNG LW; KOHMURA M; ARIYOSHI Y; KIM SH
      STRUCTURE OF AN ENANTIOMERIC PROTEIN, D-MONELLIN AT 1.8 ANGSTROM RESOLUTION

      Acta crystallographica. Section D, Biological crystallography
    17. FURUSE K; FUKUOKA M; NISHIWAKI Y; KURITA Y; WATANABE K; NODA K; ARIYOSHI Y; TAMURA T; SAIJO N
      PHASE-III STUDY OF INTENSIVE WEEKLY CHEMOTHERAPY WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR VERSUS STANDARD CHEMOTHERAPY IN EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    18. KUDOH S; FUJIWARA Y; TAKADA Y; YAMAMOTO H; KINOSHITA A; ARIYOSHI Y; FURUSE K; FUKUOKA M; TAKADA M; IKEGAMI H; NISHIKAWA H; NAKAJIMA S; HOSO T; HIGASHINO K; TAKAHARA J; KAMEI M; YAMAKIDO M; RYU S; HARA N; FUKUDA M; KINUWAKI E; TANAKA F; SENBA H; ARAKI J
      PHASE-II STUDY OF IRINOTECAN COMBINED WITH CISPLATIN IN PATIENTS WITHPREVIOUSLY UNTREATED SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    19. ARIYOSHI Y; SHIMAHARA M
      DETERMINING WHETHER A PAROTID TUMOR IS IN THE SUPERFICIAL OR DEEP LOBE USING MAGNETIC-RESONANCE-IMAGING

      Journal of oral and maxillofacial surgery
    20. KOHMURA M; ARIYOSHI Y
      CHEMICAL SYNTHESIS AND CHARACTERIZATION OF THE SWEET PROTEIN MABINLIN-II

      Biopolymers
    21. OTA M; SHIMIZU Y; TONOSAKI K; ARIYOSHI Y
      SYNTHESIS, CHARACTERIZATION, AND SWEETNESS-SUPPRESSING ACTIVITIES OF GURMARIN ANALOGS MISSING ONE DISULFIDE BOND

      Biopolymers
    22. OTA M; SHIMIZU Y; TONOSAKI K; ARIYOSHI Y
      ROLE OF HYDROPHOBIC AMINO-ACIDS IN GURMARIN, A SWEETNESS-SUP PRESSINGPOLYPEPTIDE

      Biopolymers
    23. MITSUDOMI T; SUZUKI S; YATABE Y; NISHIO M; KUWABARN M; GOTOH K; HATOOKA S; SHINODA M; SUYAMA M; OGAWA M; TAKAHASHI T; ARIYOSHI Y; TAKAHASHI T
      CLINICAL IMPLICATIONS OF P53 AUTOANTIBODIES IN THE SERA OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER

      Journal of the National Cancer Institute
    24. NISHIO M; KOSHIKAWA T; YATABE Y; KUROISHI T; SUYAMA M; NAGATAKE M; SUGIURA T; ARIYOSHI Y; MITSUDOMI T; TAKAHASHI T; TAKAHASHI T
      PROGNOSTIC-SIGNIFICANCE OF CYCLIN D1 AND RETINOBLASTOMA EXPRESSION INCOMBINATION WITH P53 ABNORMALITIES IN PRIMARY, RESECTED NONSMALL CELLLUNG CANCERS

      Clinical cancer research
    25. HAMAJIMA N; INOUE M; TAJIMA K; TOMINAGA S; MATSUURA A; KOBAYASHI S; ARIYOSHI Y
      LIFE-STYLE AND ANTI-HELICOBACTER PYLORI IMMUNOGLOBULIN-G ANTIBODY AMONG OUTPATIENTS

      Japanese journal of cancer research
    26. HUNG LW; KOHMURA M; ARIYOSHI Y; KIM SH
      CRYSTALLIZATION AND PRELIMINARY-X-RAY ANALYSIS OF D-MONELLIN

      Acta crystallographica. Section D, Biological crystallography
    27. ARAI Y; INABA Y; TAKEUCHI Y; ARIYOSHI Y
      INTERMITTENT HEPATIC ARTERIAL INFUSION OF HIGH-DOSE 5FU ON A WEEKLY SCHEDULE FOR LIVER METASTASES FROM COLORECTAL-CANCER

      Cancer chemotherapy and pharmacology
    28. GOODMAN M; KENT D; ZANETTI M; GERLONI M; KOHMURA M; ARIYOSHI Y
      AN IMMUNOLOGICAL APPROACH TO THE STRUCTURAL BASIS OF THE SWEET TASTE

      Pure and applied chemistry
    29. FURUSE K; NAKA N; TAKADA M; KINUWAKI E; KUDO S; TAKADA Y; YAMAKIDO M; YAMAMOTO H; FUKUOKA M; RYU S; HARA N; TAKAHARA J; HIGASHINO K; HOSO T; ARAKI J; IGARASHI T; TANIO Y; NISHIKAWA H; ASAMOTO H; NAKANO M; SAWA T; ARIYOSHI Y; IKEGAMI H; NAKAJIMA S; SENDA H
      PHASE-II STUDY OF 3-HOUR INFUSION OF PACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-III AND STAGE-IV NONSMALL CELL LUNG-CANCER

      Oncology
    30. MIZUKOSHI T; KOHMURA M; SUZUKI EI; ARIYOSHI Y
      STRUCTURE AND DYNAMIC STUDIES BY NMR OF THE POTENT SWEET PROTEIN MONELLIN AND A NON-SWEET ANALOG - EVIDENCE ON THE IMPORTANCE OF RESIDUE ASP(B7) FOR SWEET TASTE

      FEBS letters
    31. ANDOH T; NISHIZAWA M; HIDA T; ARIYOSHI Y; TAKAHASHI T; UEDA R
      REDUCED EXPRESSION OF DNA TOPOISOMERASE-II CONFERS RESISTANCE TO ETOPOSIDE (VP-16) IN SMALL-CELL LUNG-CANCER CELL-LINES ESTABLISHED FROM A REFRACTORY TUMOR OF A PATIENT AND BY IN-VITRO SELECTION

      Oncology research
    32. KAWAGUCHI H; FUJIMOTO K; NAKAZAWA Y; SAKAGAWA M; ARIYOSHI Y; SHIDARA M; OKAZAKI H; EBISAWA Y
      MODIFICATION AND FUNCTIONALIZATION OF HYDROGEL MICROSPHERES

      Colloids and surfaces. A, Physicochemical and engineering aspects
    33. KAGAMI Y; ARIYOSHI Y; HORIUCHI A; KANAMARU A; KANO Y; NAOE T; OGURO M; OHNO R; SAMPI K; SHIRAKAWA S; MASAOKA T; FURUE H
      FEASIBILITY OF SALVAGE CHEMOTHERAPY FOR REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA WITH 2 TOPOISOMERASE-II INHIBITORS, MST-16 AND VP-16

      International journal of hematology
    34. NISHIO M; KOSHIKAWA T; KUROISHI T; SUYAMA M; UCHIDA K; TAKAGI Y; WASHIMI O; SUGIURA T; ARIYOSHI Y; TAKAHASHI T; UEDA R; TAKAHASHI T
      PROGNOSTIC-SIGNIFICANCE OF ABNORMAL P53 ACCUMULATION IN PRIMARY, RESECTED NON-SMALL-CELL LUNG CANCERS

      Journal of clinical oncology
    35. TOBINAI K; HOTTA T; SAITO H; OHNISHI K; OHNO R; OGURA M; ARIYOSHI Y; TAKEYAMA K; KOBAYASHI T; OHASHI Y; SHIRAKAWA S
      COMBINATION PHASE I II STUDY OF IRINOTECAN HYDROCHLORIDE (CPT-11) ANDCARBOPLATIN IN RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA/

      Japanese Journal of Clinical Oncology
    36. MIYARA H; HIDA T; NISHIDA K; TAKAHASHI T; SUGIURA T; ARIYOSHI Y; MORISHITA M; TAKAHASHI T; UEDA R
      MODIFICATION OF CHEMO-RADIOSENSITIVITY OF A HUMAN LUNG-CANCER CELL-LINE BY INTRODUCTION OF THE GLUTATHIONE-S-TRANSFERASE-PI GENE

      Japanese Journal of Clinical Oncology
    37. SAITO H; OGAWA M; ARIYOSHI Y
      THE 11TH BB-NAGOYA-INTERNATIONAL-CANCER-TREATMENT-SYMPOSIUM CYTOKINESAND NEW ANTICANCER AGENTS ON THE HORIZON OF ONCOLOGY - 24-25 NOVEMBER1995, NAGOYA, JAPAN - PREFACE

      Cancer chemotherapy and pharmacology
    38. KUDOH S; SAWA T; KURIHARA N; FURUSE K; KURITA Y; FUKUOKA M; TAKADA M; TAKAKU F; OGAWA M; ARIYOSHI Y
      PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-3 ADMINISTRATION FOLLOWING CARBOPLATIN AND ETOPOSIDE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCERPATIENTS

      Cancer chemotherapy and pharmacology
    39. KATAKAMI N; TAKADA M; NEGORO S; OTA K; FUJITA J; FURUSE K; ARIYOSHI Y; IKEGAMI H; FUKUOKA M
      DOSE-ESCALATION STUDY OF CARBOPLATIN WITH FIXED-DOSE ETOPOSIDE PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA - A STUDY OF THE LUNG-CANCER STUDY-GROUP OF WEST JAPAN

      Cancer
    40. OTA M; TONOSAKI K; MIWA K; FUKUWATARI T; ARIYOSHI Y
      SYNTHESIS AND CHARACTERIZATION OF THE SWEETNESS-SUPPRESSING POLYPEPTIDE GURMARIN AND ENT-GURMARIN

      Biopolymers
    41. IZAWA H; OTA M; KOHMURA M; ARIYOSHI Y
      SYNTHESIS AND CHARACTERIZATION OF THE SWEET PROTEIN BRAZZEIN

      Biopolymers
    42. KOHMURA M; OTA M; IZAWA H; MING D; HELLEKANT G; ARIYOSHI Y
      ASSIGNMENT OF THE DISULFIDE BONDS IN THE SWEET PROTEIN BRAZZEIN

      Biopolymers
    43. KUDO S; KURIHARA N; FURUSE K; KURITA Y; FUKUOKA M; TAKADA M; TAKAKU F; OGAWA M; ARIYOSHI Y
      A PHASE-II STUDY OF THE RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) FOLLOWING CARBOPLATIN (CBDCA) AND ETOPOSIDE (VP-16) CHEMOTHERAPY IN PATIENTSWITH SMALL-CELL LUNG-CANCER (SCLC)

      European journal of cancer
    44. FURUSE K; NAKA N; ARIYOSHI Y; IKEGAMI H; FUKUOKA M; YAMAKIDO M
      PHASE-II STUDY OF 3-HOUR INFUSION OF PACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER (NSCLC)

      European journal of cancer
    45. ARIYOSHI Y; SHIMOJO S; MIYAHARA H
      HYPERSCORE, A DESIGN OF A HYPERTEXT MODEL FOR MUSICAL EXPRESSION AND STRUCTURE

      Journal of new music research
    46. OTA M; ARIYOSHI Y
      LOCATION OF THE DISULFIDE BONDS OF THE SWEETNESS-SUPPRESSING POLYPEPTIDE GURMARIN

      Bioscience, biotechnology, and biochemistry
    47. HORIO Y; SUZUKI H; UEDA R; KOSHIKAWA T; SUGIURA T; ARIYOSHI Y; SHIMOKATA K; TAKAHASHI T; TAKAHASHI T
      PREDOMINANTLY TUMOR-LIMITED EXPRESSION OF A MUTANT ALLELE IN A JAPANESE FAMILY CARRYING A GERMLINE P53 MUTATION

      Oncogene
    48. OISO Y; TOMITA A; HASEGAWA H; ARIYOSHI Y; NIINOMI M; YAMAMOTO M; TAKANO T; SAKIYAMA N
      PAMIDRONATE TREATMENT IN PATIENTS WITH TUMOR-ASSOCIATED HYPERCALCEMIA- PHARMACOLOGICAL EFFECTS AND PHARMACOKINETICS

      Endocrine journal
    49. KOHMURA M; NIO N; ARIYOSHI Y
      SOLID-PHASE SYNTHESIS AND STRUCTURE-TASTE RELATIONSHIPS OF ANALOGS OFTHE SWEET PROTEIN MONELLIN

      Bioscience, biotechnology, and biochemistry
    50. WASHIMI O; UEDA R; ARIYOSHI Y; SUYAMA M; SEKI T; TAKAHASHI T; TAKAHASHI T
      EXPRESSION OF CD44 VARIANT ISOFORMS IN NORMAL AND NEOPLASTIC-CELLS OFTHE LUNG

      Japanese journal of cancer research
    51. OGAWA M; ARIYOSHI Y
      NEW ANTICANCER DRUGS UNDER CLINICAL-TRIALS IN JAPAN

      Hematology/oncology clinics of North America
    52. ARIYOSHI Y; FUKUOKA M; FURUSE K; SAIJO N; IKEGAMI H; NISHIWAKI Y; TAMURA T; SHIMOYAMA M; SUEMASU K
      CONCURRENT CISPLATIN-ETOPOSIDE CHEMOTHERAPY PLUS THORACIC RADIOTHERAPY FOR LIMITED-STAGE SMALL-CELL-LUNG CANCER

      Japanese Journal of Clinical Oncology
    53. ARAI Y; SONE Y; INABA Y; ARIYOSHI Y; KIDO C
      HEPATIC ARTERIAL INFUSION CHEMOTHERAPY FOR LIVER METASTASES FROM BREAST-CANCER

      Cancer chemotherapy and pharmacology
    54. ARIYOSHI Y; NIITANI H; FUJIMURA S; NISHIWAKI Y; HORAI T; SAITO Y; MASAOKA A; SHIMOSATO Y; NARUKE T; TSUCHIYA R
      1ST ASIAN LUNG-CANCER WORKSHOP - RECENT DEVELOPMENTS AND CONTROVERSIES IN SQUAMOUS-CELL CARCINOMA OF THE LUNG - NATIONAL-CANCER-CENTER-HOSPITAL, TOKYO, JULY 1-2, 1993 - ABSTRACTS

      Lung cancer
    55. ARIYOSHI Y
      SOLID-PHASE SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANALOGSOF THE SWEET PROTEIN MONELLIN

      Yuki Gosei Kagaku Kyokaishi
    56. HIDA T; UEDA R; SEKIDO Y; HIBI K; MATSUDA R; ARIYOSHI Y; SUGIURA T; TAKAHASHI T; TAKAHASHI T
      ECTOPIC EXPRESSION OF C-KIT IN SMALL-CELL LUNG-CANCER

      International journal of cancer
    57. HIDA T; KUWABARA M; ARIYOSHI Y; TAKAHASHI T; SUGIURA T; HOSODA K; NIITSU Y; UEDA R
      SERUM GLUTATHIONE-S-TRANSFERASE-PI LEVEL AS A TUMOR-MARKER FOR NONSMALL CELL LUNG-CANCER - POTENTIAL PREDICTIVE VALUE IN CHEMOTHERAPEUTIC RESPONSE

      Cancer
    58. IIDA S; SETO M; YAMAMOTO K; KOMATSU H; TOJO A; ASANO S; KAMADA N; ARIYOSHI Y; TAKAHASHI T; UEDA R
      MLLT3 GENE ON 9P22 INVOLVED IN T(9-11) LEUKEMIA ENCODES A SERINE PROLINE-RICH PROTEIN HOMOLOGOUS TO MLLT1 ON 19P13

      Oncogene
    59. YAMAMOTO K; SETO M; KOMATSU H; IIDA S; AKAO Y; KOJIMA S; KODERA Y; NAKAZAWA S; ARIYOSHI Y; TAKAHASHI T; UEDA R
      2 DISTINCT PORTIONS OF LTG19 ENL AT 19P13 ARE INVOLVED IN T(11 19) LEUKEMIA/

      Oncogene
    60. ARIYOSHI Y
      ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS DERIVED FROM FOOD PROTEINS

      Trends in food science & technology
    61. OTA M; NIO N; ARIYOSHI Y
      ENZYMATIC-SYNTHESIS AND CHEMICAL-PROPERTIES OF SWEET AMINOMALONYL (AMA) DIPEPTIDE ESTERS (R)-AMA-(S)-PHE-OME AND (R)-AMA-(S)-PHE-OET

      Bioscience, biotechnology, and biochemistry
    62. IIDA S; SETO M; YAMAMOTO K; KOMATSU H; AKAO Y; NAKAZAWA S; ARIYOSHI Y; TAKAHASHI T; UEDA R
      MOLECULAR-CLONING OF 19P13 BREAKPOINT REGION IN INFANTILE LEUKEMIA WITH T(11-19)(Q23-P13) TRANSLOCATION

      Japanese journal of cancer research
    63. HIDA T; ARIYOSHI Y; SUGIURA T; SUYAMA M; TAKAHASHI T; UEDA R
      SYNCHRONOUS LUNG-CANCER PRESENTING WITH SMALL-CELL CARCINOMA AND ADENOCARCINOMA

      Chest
    64. WASHIZU K; KIMURA S; HIRAIWA H; MATSUNAGA K; KUWABARA M; ARIYOSHI Y; KATO K; TAKEUCHI K
      DEVELOPMENT AND APPLICATION OF AN ENZYME-IMMUNOASSAY FOR TENASCIN

      Clinica chimica acta


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 22:47:08